Posted on 2 February 2022

PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022

PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it highlights VIVEbiotech as one of the ten Spanish biotechs to follow in 2022.

In addition to Minoryx Therapeutics, Oryzon Genomics, Ona Therapeutics, Aelix Therapeutics, Peptomyc, Highlight Therapeutics, Algenex, InnoUp Farma and Chemotargets, VIVEbiotech has been listed as one of the ten Spanish biotech companies to watch in 2022.

VIVEbiotech is, indeed, the only Spanish CDMO that develops and manufactures lentiviral vectors to be used in clinical trials in humans. To read the full article, you can click here. Many thanks to PharmaBoardroom for this recognition!